German OTC Market Woes Continue
Germany's OTC market blues continue as the coronavirus lockdown bites into May.
You may also be interested in...
OTC marketing news from Germany: A hard-won desloratadine launch from Novartis, two new products from Dermapharm, as well as homeopathic and probiotic alternatives from Hevert and Bencard.
IQVIA Consumer Health's analysis of the impact of the coronavirus pandemic on Europe's OTC market based on the latest sales data.
A weak cold season last year and a booming online pharmacy market in Germany contributed to a significant decline in the number of "grünes Rezept" recommendation prescriptions issued in the country in 2019, according to new data from IQVIA.